ACAude Couturier

Aude Couturier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aude Couturier has a total of 192 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Regional Scleral and Choroidal Thickness Analysis in Highly Myopic Eyes using Ultra-Widefield Swept-Source Optical Coherence Tomography Angiography

    by Matteo Mario Carlà, Aude Couturier, Vivien Vasseur, Sebastiano Del Fabbro, Ali Erginay, Jost B. Jonas, Alain Gaudric, Elise Philippakis

  • PIGMENT EPITHELIUM DETACHMENT IN SEVERE ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY

    by Alexandre Dentel, Chloé Widehen, Paul Goupillou, Florence Hoogewoud, Sarah Mrejen, Christine Fardeau, Cherif Titah, Mohamed A. Gargouri, Aude Couturier, Alain Gaudric, et al.

    Purpose: To describe the spectrum of optical coherence tomography (OCT) findings in acute posterior multifocal placoid pigment epitheliopathy (APMPPE), with a specific focus on the prevalence of pigment epithelium detachments (PEDs). Methods: Multicenter, retrospective, longitudinal study including patients diagnosed with APMPPE based on color fundus photography, OCT, and fluorescein angiography. Demographics, visual acuity, and the following OCT findings were assessed: outer retinal hyperreflectivity, serous retinal detachment (SRD), bacillary layer detachment (BALAD), and PED. Results: Forty-six eyes of 27 patients were included. The median age at presentation was 23 years (range: 18–36 years), and 17 patients (62.9%) were men. At baseline, outer retinal hyperreflectivity was found in all eyes, while BALAD, SRD, and PED were observed in 22 (47.8%), 14 (30.4%), and 26 eyes (56.5%), respectively. A univariate logistic regression showed a significant association between the presence of PED and a worse baseline visual acuity (odds ratio [OR]: 5.3; 95% confidence interval [CI]: 1.5–18.6; P = 0.01), the presence of BALAD (OR: 9.0; 95% CI: 2.3–35.6; P = 0.002), and the presence of SRD (OR: 7.3; 95% CI: 1.4–38.3; P = 0.02). Conclusion: PEDs were significantly associated with a poorer initial visual acuity, as well as with the presence of BALAD and SRD on presentation. These findings suggest that PEDs could be used as a biomarker of disease severity and choriocapillaris ischemia in APMPPE.

  • Open Access

    Myopic Traction Maculopathy

    by Aude Couturier, Chui Ming Gemmy Cheung, Richard Spaide, Kyoko Ohno-Matsui, Gemmy Cheung Chui Ming, Salomon Yves Cohen, Aude Couturier, David Gaucher, Alain Gaudric, Jost B. Jonas, et al.

  • Open Access

    Scleral buckling under a slit-lamp illumination system in patients with primary rhegmatogenous retinal detachment

    by Vasileia Chatzistergiou, Boris Marguier, Pierre Negrier, Aude Couturier, Elise Philippakis

    Purpose: To present the slit-lamp illumination and visualisation system for scleral buckling for primary rhegmatogenous retinal detachment (RRD) and assess its feasibility and postoperative outcomes. Methods: In a retrospective, single-center, non-comparative case series, patients with subtotal RRD who underwent scleral buckling under a slit-lamp illumination system at Lariboisière Hospital, between May 2017 and May 2022, were included. Patients who underwent scleral buckling combined with vitrectomy, with a history of retinal surgery and with maculopathies interfering with visual acuity were excluded. The following preoperative data were collected: best-corrected visual acuity (BCVA), number and location of retinal breaks, extend of the detachment, presence of macular detachment. The fundus was visualised using a quadraspheric lens, and the slit-lamp system integrated in the surgical microscope. Anatomical success rate, BCVA improvement and complications were collected. Results: Forty-six eyes of 46 patients with a mean age of 43.2 ± 12.8 years, followed for 8.7 ± 8.3 months were included. No procedure was switched to vitrectomy during surgery. The single surgery success rate was 93.5% (43 eyes). Three eyes had to undergo vitrectomy due to vitreoretinal proliferation. BCVA improved from 0.63 ± 0.76 LogMAR (Snellen 20/80) before surgery to 0.33 ± 0.40 LogMAR (Snellen 20/40) after surgery (p=0.002). Intraoperative and postoperative complications were experienced by two and nine patients, respectively. Conclusion: Scleral buckling using a surgical microscope with an integrated slit-lamp and a wide-angle contact lens is a feasible technique associated with satisfactory anatomical and functional outcomes. This approach was associated with a high single-surgery success rate and a manageable complication rate. Clinical trial number: Not applicable.

  • Multimodal imaging for quantifying atrophic lesions in pathologic myopia

    by Karolina Motloch, Omar Moukadem, Paul Goupillou, Alain Gaudric, Aude Couturier, Elise Philippakis

    Objectives To assess the reliability and agreement of four imaging modalities in quantifying patchy atrophy in highly myopic (HM) eyes. Methods Atrophy area was manually delineated by two independent graders and measured using an in-built feature with four imaging modalities: infrared imaging with OCT B-scan (IR + SD-OCT), blue-light fundus autofluorescence (BAF), ultra-wide-field (UWF) pseudocolor fundus photography (PCFP) and UWF green fundus autofluorescence (GAF). Intragrader, intergrader and interdevice agreements were then assessed. Results Thirty-two eyes of 30 patients were included. The mean axial length was 30.31 ± 1.56 mm. From 128 analyzed images, the best intragrader repeatability was observed with IR + SD-OCT for both graders (ICC = 0.998 and 0.999), followed by BAF (ICC = 0.998 and 0.997), UWF PCFP (ICC = 0.992 and 0.999) and UWF GAF (ICC = 0.967 and 0.985). IR + SD-OCT was also superior in terms of intergrader repeatability (ICC = 0.999), followed by ICC = 0.998 for BAF, ICC = 0.996 for UWF PCFP, and ICC = 0.985 for UWF GAF. The atrophy areas measured using each device correlated (r = 0.958–0.995; all p < 0.001), but differed significantly (p < 0.001). PCFP and BAF measured respectively the smallest and largest median area (2.14 mm² [IQR: 3.88 mm²] and 2.90 mm² [IQR: 5.28 mm²], respectively). A larger lesion size was associated with greater interdevice disagreement. Conclusion All imaging modalities provided reliable atrophy area measurements, which correlated but differed significantly. IR + SD-OCT showed the strongest agreement.

  • Effect of high lipid exposure on retinal glial cell activation

    by Aude Couturier

    Effet de l’exposition aux lipides sur l’activation des cellules gliales rétiniennes: La rétinopathie diabétique (RD) reste la première cause de cécité dans la population active dans les pays industrialisés et les traitements actuels ne sont pas totalement satisfaisants. De nombreuses études ont démontré l’implication précoce de l’activation des cellules gliales de Müller (CGMs) dans la survenue de la RD, même avant l’apparition des lésions vasculaires. Par ailleurs, le glucose ne serait pas le seul facteur impliqué dans ces modifications vasculaires et inflammatoires, et des études récentes ont montré le rôle de la dyslipidémie et des acides gras dans la RD. L’objectif de ce travail était d’évaluer la réaction inflammatoire et angiogénique des CGMs en réponse à l’hyperglycémie et l’hyperlipidémie. Dans ce travail, nous avons tout d’abord décrit la première production de CGMs à partir de cellules souches pluripotentes de différentes origines (hiMGCs), puis évaluer leur réponse aux différents stimuli de la RD. L’étude de la transcriptomique a montré que les hiMGCs exprimaient 18 protéines clé des CGMs. Tout comme les CGMs primaires, les hiMGCs répondent peu à l’hyperglycémie mais sont très activées par l’exposition aux acides gras, notamment le palmitate. Enfin, nous avons montré que le palmitate stimulait la sécrétion par les hiMGCs de facteurs pro-angiogéniques, tels que le VEGF, l’IL-8, l’IL1 ß et ANGPTL4 et que les hiMGCs exposées au palmitate exerçaient une activité pro-angiogénique ex-vivo. Ainsi, ces hiMGCs, qui peuvent être générées à partir de donneurs sains et facilement multipliées représentent un outil fiable pour mieux comprendre les mécanismes complexes impliqués dans la RD et pour le développement de nouvelles thérapeutiques.

  • Prognostic value of foveal choroidal vascular hyperpermeability on indocyanine green angiography in central serous chorioretinopathy

    by Sofiane Khamkhoum, Francine Behar Cohen, Aude Couturier, Alain Gaudric, Elodie Bousquet

    Background To assess the association between the foveal location of choroidal vascular hyperpermeability (CVH) on indocyanine green angiography (ICGA) at the first visit and the visual acuity at the end of the follow-up in central serous chorioretinopathy (CSC). Methods This retrospective, observational, longitudinal study was conducted in the ophthalmology department of Lariboisière Hospital, Paris, France. Patients with CSC who underwent multimodal imaging, including ICGA, with a follow-up of more than 3 years, were included. The Early Treatment of Diabetic Retinopathy Study (ETDRS) grid was superimposed over mid-phase ICGA images at the first visit to determine CVH location. CVH were classified according to the location of the lesion within the central 3-mm ETDRS circle. Results Eighty-four eyes of 68 patients with a mean follow-up duration of 6.5 ± 3 years were included. Patients’ mean age was 48.3 ± 14.3 years and 59 patients (86.8%) were men. A foveal CVH was identified in 60 eyes (71.4%). The multivariate analysis showed an association between a final visual acuity worse than 0.3 logMAR (20/40 Snellen equivalent) and a lower initial visual acuity (p = 0.001), the presence of gravitational tracts (p = 0.034) and a foveal CVH at the first visit (p = 0.026). Conclusion This study suggested that the presence of a foveal CVH is associated with a decline in visual acuity over time. Our findings highlighted the importance of performing ICGA at the first visit to assess disease severity and guide the monitoring of CSC patients.

  • Consensus Recommendations on the Use of Per- and Polyfluoroalkyl Substances-Containing Ocular Endotamponades

    by Mario R. Romano, Mariantonia Ferrara, Martin Zinkernagel, David H. Steel, Salvador Pastor-Idoate, Antonio Boccardi, Aude Couturier, Jana D’AMato Tothova, Vivek Pravin Dave, Belma Dikme, et al.

    We conducted an expert-led consensus to develop recommendations on the use of per- and polyfluoroalkyl substances (PFAS)-containing ocular endotamponades (OEs) in vitreoretinal surgery, aiming to promote a more sustainable surgical practice. We used a modified Delphi methodology with panel consisting of fourteen vitreoretinal surgeons and five representatives of companies involved in OEs production and marketing. Based on a literature review and the latest updates on European Union’s PFAS restriction proposal, the facilitator prepared a list of statements on PFAS-containing OEs currently used. Each statement was graded individually using a nine-point scale (from 1 “absolutely disagree” to 9 “absolutely agree”) and the consensus was defined as a score between 7 and 9 from ≥80% of members. After two rounds, and related discussion, the recommendations highlighted the crucial role of PFAS-containing OEs in surgical practice and the potential negative impact of their ban on patients’ outcomes. There was a strong agreement on the need of perfluorocarbon liquids as intraoperative tool, although it was also pointed out that their use should be avoided if possible. Fluorinated gases were deemed essential with no agreement on the possibility to replace SF6 and/or C2F6 with C3F8 at different concentrations. Conversely, semifluorinated alkanes as rinsing solution as well as F6H8 were considered extraneous. No consensus was reached about the current role of heavy silicone oils. Finally, the use of air as alternative and environment-friendly OE was judged not supported by sufficient evidence but worth of further investigation.

  • Open Access

    Real-world faricimab switch in France: artificial intelligence-based detection of changes in exudative signs in difficult-to-treat neovascular age-related macular degeneration

    by Vincent Gualino, Charles Sohier, Maxime Sibert, Ali Erginay, Fanny Varenne, Jacqueline Butterworth, Aude Couturier, Pierre-Henry Gabrielle, Vincent Soler, Catherine Creuzot-Garcher

    Purpose: Some patients with neovascular age-related macular degeneration (nAMD) have persistent signs of exudation under treatment with intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents. We examined the real-world anatomical responses among patients with suboptimal response and switched to faricimab using artificial intelligence (AI)-based retinal fluid quantification. Methods: A retrospective, multicentric, cohort study of patients in France with exudative signs and switched to faricimab without a new loading phase, maintaining the same prior injection interval. The RetInSight Fluid Monitor AI software quantified subretinal (SRF) and intraretinal (IRF) fluid on spectral domain optical coherence tomography. The primary outcome was change in SRF and IRF volumes in the central 1 and 6 mm retinal areas after one and two injections of faricimab. Results: 74 patients (74 eyes) were included (mean age: 81.5±8.4 years, 49% male). Significant reductions were observed in mean 1 mm IRF (−2.9±18.3 nl; p=0.002), mean 6 mm IRF (−17.7±71.1 nl; padj OR 0.965; p=0.028) and lower baseline IRF volumes were predictive of dry response after two injections ( adj OR 0.373; p=0.051). Conclusion: Nearly half of patients achieved a dry response after two injections. AI-assisted fluid quantification provided objective monitoring, identifying lower baseline SRF and IRF as predictive factors for good response. Limited patient inclusion means longer-term and larger prospective studies are now required using automated retinal fluid quantification to further refine the baseline characteristics of good switch responders to better adapt switch protocols.


  • Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration – The SWIFT study

    by A. Couturier, E.H. Souied, C. Creuzot-Garcher, S.Y. Cohen, L. Kodjikian, S. Baillif, M.-N. Delyfer, M. Weber, I. Aubry-Quenet, A. Ponthieux, et al.